Cardinal Health, Inc. (CAH) FY2026 YTD Q3 P&L / Income Statement

Revenue by Business Segment

2025-07-01 to 2026-03-31

Swipe to see the full flow
Cardinal Health, Inc. (CAH) FY2026 YTD Q3 P&L / Income StatementIncome statement for 2025-07-01 through 2026-03-31. View: Business segment. Revenue uses this breakdown; costs and expenses retain the consolidated categories.SOURCESREVENUE RECONCILIATIONREVENUEGROSSOPERATINGPRE-TAXNETPharmaceutical and Specialty SolutionsCost of product soldOther SegmentsRevenueRevenue before reconciliation (calculated)CorporateGross marginCost of products soldOperating earningsOperating costs, net of other operating items (calculated)Distribution, selling, general and administrative expensesAcquisition-related cash and share-based compensation costsImpairments and (gain)/loss on disposal of assets, netRestructuring and employee severanceLitigation (recoveries)/charges, netAmortization and other acquisition-related costsEarnings/(loss) before income taxesOther income (expense), net (calculated)Net earnings/(loss)Provision for income taxesRevenue before reconciliation (calculated)Revenue beforereconciliation(calculated)$190.65 BEarnings/(loss) before income taxesEarnings/(loss)before income taxes$1.62 BRevenueRevenue$190.58 BGross marginGross margin$7.21 BOperating earningsOperating earnings$1.88 BNet earnings/(loss)Net earnings/(loss)$1.31 BOperating costs, net of other operating items (calculated)Operating costs,net (calculated)$5.33 BCost of products soldCost of products sold$183.36 BProvision for income taxesProvision forincome taxes$315.00 MDistribution, selling, general and administrative expensesDistribution, selling, generaland administrative expenses$4.51 BOther income (expense), net (calculated)Other income,net (calculated)−$264.00 MPharmaceutical and Specialty SolutionsPharmaceutical andSpecialty Solutions$175.99 BAcquisition-related cash and share-based compensation costsAcquisition-related cash andshare-based compensation costs$243.00 MImpairments and (gain)/loss on disposal of assets, netImpairments and (gain)/losson disposal of assets, net$173.00 MCost of product soldCost of product sold$9.59 BRestructuring and employee severanceRestructuring andemployee severance$66.00 MOther SegmentsOther Segments$5.07 BLitigation (recoveries)/charges, netLitigation(recoveries)/charges, net−$7.00 MCorporateCorporate−$71.00 MAmortization and other acquisition-related costsAmortization and otheracquisition-related costs$348.00 M
Chart details

Cardinal Health, Inc. (CAH) FY2026 YTD Q3 P&L / Income Statement

Income statement for 2025-07-01 through 2026-03-31. View: Business segment. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

Revenue
190,576,000,000 US dollars
Cost of products sold
183,362,000,000 US dollars
Gross margin
7,214,000,000 US dollars
Operating costs, net of other operating items (calculated)
5,330,000,000 US dollars
Operating earnings
1,884,000,000 US dollars
Other income (expense), net (calculated)
negative 264,000,000 US dollars
Earnings/(loss) before income taxes
1,620,000,000 US dollars
Provision for income taxes
315,000,000 US dollars
Net earnings/(loss)
1,305,000,000 US dollars
Pharmaceutical and Specialty Solutions
175,985,000,000 US dollars
Cost of product sold
9,591,000,000 US dollars
Other Segments
5,071,000,000 US dollars
Distribution, selling, general and administrative expenses
4,507,000,000 US dollars
Restructuring and employee severance
66,000,000 US dollars
Amortization and other acquisition-related costs
348,000,000 US dollars
Acquisition-related cash and share-based compensation costs
243,000,000 US dollars
Impairments and (gain)/loss on disposal of assets, net
173,000,000 US dollars
Litigation (recoveries)/charges, net
negative 7,000,000 US dollars
Revenue before reconciliation (calculated)
190,647,000,000 US dollars. Sum of the reported revenue categories before the separately reported reconciliation.
Corporate
negative 71,000,000 US dollars. Reported reconciliation to consolidated revenue.
Pharmaceutical and Specialty Solutions costs
173,847,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.
Cost of product sold costs
9,483,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.
Other Segments costs
4,547,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.
Reconciling items (calculated)
815,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.

Chart connections

  • Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
  • Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
  • Reported revenue categories plus the separately reported signed reconciliation equals consolidated revenue.
  • Of which attributable to Cardinal Health, Inc.: $1.32 B; to noncontrolling interests: −$11.00 M.
Cardinal Health, Inc. (CAH) FY2026 YTD Q3 P&L / Income Statement Sankey chart, Business segment view
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Gross margin

3.8%

Gross profit / revenue

Operating margin

1.0%

Operating profit / revenue

Cash conversion

266.8%

Operating cash / net income, same period

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!